Core Viewpoint - Kintor Pharmaceutical Co., Ltd. (02171.HK) announced that the Yijie Biotechnology Holdings Limited and its concerted parties have cumulatively purchased 335,000 shares between November 6, 2025, and December 17, 2025, increasing their stake to approximately 38.2% of the total issued shares excluding treasury shares as of the announcement date [1]. Group 1 - Yijie Biotechnology Holdings Limited and its concerted parties are collectively referred to as the "Yijie Concerted Action Group" [1]. - The total number of shares held by the Yijie Concerted Action Group after the purchase is 218,283,730 shares [1]. - The purchase of shares indicates a significant increase in ownership percentage, reflecting confidence in the company [1].
科济药业-B(02171.HK)获益杰一致行动集团增持33.5万股